The Prognostic and Diagnostic Value of Ferritin in Critically Ill Patients With Special Focus on Underlying Hemophagocytic Lymphohistiocytosis

Hemophagocytic lymphohistiocytosis

L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH Ruxolitinib as First Line Treatment in Primary Haemophagocytic Lymphohistiocytosis (R-HLH) A Post-authorization Study to Describe the Safety and Efficacy of Emapalumab for the Treatment of pHLH in Treatment Experienced Chinese Patients Response Prediction in EBV-HLH Using Metabonomics Analysis Assessing the Presence of CT-DNA in Lymphoma Associated HLH Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH Efficacy and Safety of Venetoclax Combined With Dexamethasone and Etoposide in HLH Cytokine Guided Risk Stratification and Treatment in Pediatric Hemophagocytic Lymphohistiocytosis Rituximab Monotherapy for EBV-HLH and CAEBV L-DEP/DEP Regimen and PD-1 Antibody as a Treatment for Relapse/Refractory EBV-HLH DEP Combine With PD-1 Antibody as an Initial Treatment for EBV-HLH Chidamide Combines With VP-16 and Methylprednisolone in the Treatment of HLH A Prospective Clinical Study of Ruxolitinib and Etoposide Combined With DDGP Regimen (RUE-DDGP) in Induction Therapy of T/NK Cell Lymphoma-associated Hemophagocytic Syndrome. Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis Evaluate the Efficacy and Safety of PEG-rhG-CSF in Patients With Hemophagocytic Syndrome Ruxolitinib Combined With Dexamethasone for HLH Long-term Follow-up of HLH Patients Who Received Treatment With NI-0501, an Anti-interferon Gamma Monoclonal Antibody Retrospective Study of Immunotherapy Related Toxicities in Children and Adults With Cancer A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH Study to Assess the Efficacy and Safety of Emapalumab in Primary Haemophagocytic Lymphohistiocytosis Treatment of Familiar Lymphohistiocytosis DEP-Ru Regimen as a Salvage Therapy for HLH Etoposide in the First-line Treatment of Adult EBV-HLH Splenectomy as a Treatment for Patient With Relapsed Haemophagocytic Lymphohistiocytosis of Unknown Etiology Prospective Cohort for Adult Hemophagocytosis The Prognostic and Diagnostic Value of Ferritin in Critically Ill Patients With Special Focus on Underlying Hemophagocytic Lymphohistiocytosis A Study to Investigate the Safety and Efficacy of an Anti-IFNγ mAb in Children Affected by Primary Haemophagocytic Lymphohistiocytosis Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004 L-DEP as an Initial Treatment for EBV-HLH Trial of DA-EPOCH Regimen for NHL With HLH Tocilizumab and Hemophagocytic Lymphohistiocytosis (HLH) Ruxolitinib as a Salvage Therapy for Hemophagocytic Lymphohistiocytosis Pegylated Liposomal Doxorubicin as a Induction Therapy for Lymphoma Induced Hemophagocytic Lymphohistiocytosis. A Study of TQ05105 Tablets in Subjects With Hemophagocytic Lymphohistiocytosis（HLH） Study to Evaluate Interferon Gamma (IFNγ) and Other Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis (M-HLH) Diagnostic Biomarkers for Adult Hemophagocytic Lymphohistiocytosis in Critically Ill Patients (HEMICU) Pilot Study of Etoposide-based Therapy and Hematopoietic Cell Transplantation for Hemophagocytic Lymphohistiocytosis Hybrid Immunotherapy for Hemophagocytic LymphoHistiocytosis L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic Lymphohistiocytosis